Ken Takanashi

CIK: 0001657768

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WVE

Wave Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

WVE
Wave Life Sciences, Inc.
Oct 5, 2026
Award(A)
Direct
10.7K shares-
WVE
Wave Life Sciences, Inc.
Aug 11, 2026
Sale(S)
Direct
3.9K shares at avg. $6.01$23K
WVE
Wave Life Sciences Ltd.
Mar 23, 2026
Conversion(C)
Indirect
3.9M shares-
WVE
Wave Life Sciences Ltd.
Aug 11, 2025
Award(A)
Direct
12.7K shares-
WVE
Wave Life Sciences Ltd.
Aug 5, 2025
Sale(S)
Direct
4.9K shares at avg. $8.75$43K

		Type	Shares	Price		Ownership
Oct 5, 2026	WVE Wave Life Sciences, Inc.	Award(A)	10,700	-	$0	Direct
Aug 11, 2026	WVE Wave Life Sciences, Inc.	Sale(S)	3,864	$6.01	$23,223	Direct
Mar 23, 2026	WVE Wave Life Sciences Ltd.	Conversion(C)	3,901,348	-	$0	Indirect
Aug 11, 2025	WVE Wave Life Sciences Ltd.	Award(A)	12,700	-	-	Direct
Aug 5, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	4,872	$8.75	$42,630	Direct

1-5 of 5 transactions

About TAKANASHI KEN

TAKANASHI KEN (SEC CIK 0001657768) files insider reports with the SEC as Director of Wave Life Sciences, Inc. (WVE).

Signal8 holds 5 ownership filings by TAKANASHI KEN, all Form 4s, filed between Aug 7, 2025 and Oct 7, 2026. Those filings report 5 transactions, from Aug 5, 2025 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on TAKANASHI KEN's filings is in KAGOSHIMA.

Recent filings by TAKANASHI KEN

Oct 5, 2026: Grant or award of WVE shares (Form 4, code A).
Aug 11, 2026: Open-market sale of WVE shares (Form 4, code S).
Mar 23, 2026: Conversion of WVE shares (Form 4, code C).
Aug 11, 2025: Grant or award of WVE shares (Form 4, code A).
Aug 5, 2025: Open-market sale of WVE shares (Form 4, code S).

Other insiders filing for Wave Life Sciences, Inc. (WVE)

How to read Form 4 transaction codes